Bartolucci et al developed a score for predicting the risk for the acute chest syndrome in a patient with sickle cell disease who is experiencing a vaso-occlusive crisis. This can help to identify a patient who may benefit from more aggressive management. The authors are from Henri Mondor Hospital in Creteil, France.
Patient selection: sickle cell disease with vaso-occlusive crisis
Outcome: acute chest syndrome (ACS)
Parameters from Day 1:
(1) reticulocyte count in 10^9/L
(2) categorical pain scale in spine and/or pelvis
(3) white blood cell (WBC) count in 10^9/L
(4) hemoglobin in g/dL
Parameter |
Finding |
Points |
reticulocyte count |
<= 216 |
0 |
|
> 216 |
6 |
pain in spine and/or pelvis |
0 or 1 (no or mild pain) |
0 |
|
2 (moderate pain) |
4 |
|
3 (severe pain) |
6 |
WBC count |
<= 11 |
0 |
|
> 11 |
3 |
hemoglobin |
> 9 g/dL |
0 |
|
<= 9 g/dL |
1 |
total score =
= SUM(points for all 4 parameters)
Interpretation:
• minimum score: 0
• maximum score: 16
• The higher the score the greater the risk for the patient having the acute chest syndrome.
Total Score |
Risk ACS |
0 to 5 |
low |
6 to 10 |
intermediate |
11 to 16 |
high |
Performance:
• The area under the ROC curve was 0.84.
Specialty: Pulmonology, Genetics, Hematology Oncology